Articles by Andrew J. Karter, PhD

Language Barriers and LDL-C/SBP Control Among Latinos With Diabetes
ByAlicia Fernandez, MD,E. Margaret Warton, MPH,Dean Schillinger, MD,Howard H. Moffet, MPH,Jenna Kruger, MPH,Nancy Adler, PhD,Andrew J. Karter, PhD Among Latino patients with diabetes, ethnicity and language barriers were not associated with lipid and blood pressure control despite their associations with glycemic control in prior research.
Check out our website’s new table/figure pop-up feature! Click on the name of a table or figure in the text to see it in your browser.

Patients Who Self-Monitor Blood Glucose and Their Unused Testing Results
ByRichard W. Grant, MD, MPH,Elbert S. Huang, MD, MPH,Deborah J. Wexler, MD, MSc,Neda Laiteerapong, MD, MS,E. Margaret Warton, MPH,Howard H. Moffet, MPH,Andrew J. Karter, PhD This article identifies patient-, provider-, and system-level factors associated with the problem of self-monitoring blood glucose without use of the results.

Safety and Effectiveness of Mail Order Pharmacy Use in Diabetes
ByJulie A. Schmittdiel, PhD,Andrew J. Karter, PhD,Wendy T. Dyer, MS,James Chan, PharmD, PhD,O. Kenrik Duru, MD, MSHS Patients using mail order pharmacies have lower healthcare utilization, but somewhat less laboratory monitoring of persistent medications and slightly higher contraindicated medication use.

Differences in the Clinical Recognition of Depression in Diabetes Patients: The Diabetes Study of Northern California (DISTANCE)
ByDarrell L. Hudson, PhD, MPH,Andrew J. Karter, PhD,Alicia Fernandez, MD,Melissa Parker, MS,Alyce S. Adams, PhD,Dean Schillinger, MD,Howard H. Moffet, MPH,Jufen Zhou, MS,Nancy E. Adler, PhD Depression often goes unrecognized in primary care among symptomatic diabetes patients, especially in some minorities.

Ethnic Differences in the Development of Albuminuria: The DISTANCE Study
ByAndy I. Choi, MD, MAS,Andrew J. Karter, PhD,Jennifer Y. Liu, MPH,Bessie A. Young, MD, MPH,Alan S. Go, MD,Dean Schillinger, MD Despite uniform access to medical care, Filipinos, blacks, and Asians with diabetes developed albuminuria at higher rates than whites.

Adherence to Laboratory Test Requests by Patients With Diabetes: The Diabetes Study of Northern California (DISTANCE)
ByHoward H. Moffet, MPH,Melissa M. Parker, MS,Urmimala Sarkar, MD, MPH,Dean Schillinger, MD,Alicia Fernandez, MD,Nancy E. Adler, PhD,Alyce S. Adams, PhD,Andrew J. Karter, PhD Providers expect that patients with chronic conditions will complete necessary laboratory tests; 1 in 7 patients with diabetes did not do so within 6 months.

Mail-Order Versus Local Pharmacies on Adherence: Study Methods Make for Unfair Comparison
ByTodd A. Brown, MHP,Nathaniel M. Rickles, PhD. Reply by O. Kenrick Duru, MD, MSHS,Julie A. Schmittdiel, PhD,Wendy T. Dyer, MSc,Melissa M. Parker, MS,Connie S. Uratsu, MS,James Chan, PharmD,Andrew J. Karter, PhD 
Mail-Order Pharmacy Use and Adherence to Diabetes-Related Medications
ByO. Kenrik Duru, MD, MSHS,Julie A. Schmittdiel, PhD,Wendy T. Dyer, MSc,Melissa M. Parker, MS,Connie S. Uratsu, MS,James Chan, PharmD,Andrew J. Karter, PhD Patients with diabetes were more likely to have good medication adherence if they refilled their medications by mail versus at localpharmacies.

Glycemic Response to Newly Initiated Diabetes Therapies
ByAndrew J. Karter, PhD,Howard H. Moffet, MPH,Jennifer Liu, MPH,Melissa M. Parker, MS,Ameena T. Ahmed, MD,Alan S. Go, MD,Joe V. Selby, MD 
Effect of Cost-sharing Changes on Self-monitoring of Blood Glucose
ByAndrew J. Karter, PhD,Melissa M. Parker, MS,Howard H. Moffet, MPH,Ameena T. Ahmed, MD, MPH,James Chan, PharmD, PhD,Michele M. Spence, PhD,Joe V. Selby, MD, MPH,Susan L. Ettner, PhD 
Achieving Good Glycemic Control: Initiation of New Antihyperglycemic Therapies in Patients With Type 2 Diabetes From the Kaiser Permanente Northern California Diabetes Registry
ByAndrew J. Karter, PhD,Howard H. Moffet, MPH,Jennifer Liu, MS,Melissa M. Parker, MS,Ameena T. Ahmed, MD,Assiamira Ferrara, MD,Joe V. Selby, MD 
High Rates of Co-occurrence of Hypertension, Elevated Low-Density Lipoprotein Cholesterol, and Diabetes Mellitus in a Large Managed Care Population
ByJoe V. Selby, MD, MPH,Tiffany Peng, MS,Andrew J. Karter, PhD,Mark Alexander, PhD,Stephen Sidney, MD, MPH,Jean Lian, PhD,Amy Arnold, MS,Dan Pettitt, DVM, MS